What Is Hepatopulmonary Syndrome? When Your Liver Steals Your Breath

Hepatopulmonary syndrome (HPS) is a lung complication of liver disease where microscopic blood vessels in your lungs dilate abnormally — causing blood to pass through without picking up enough oxygen. The result: you feel breathless, your oxygen levels drop, and the shortness of breath gets worse when you stand up or sit upright (a paradoxical symptom called platypnea-orthodeoxia that's nearly unique to HPS).

HPS affects approximately 5–30% of patients being evaluated for liver transplant. Unlike hepatic hydrothorax (fluid compressing the lung), HPS is a problem of gas exchange — your lungs look structurally normal, but the blood vessels within them are too wide to function properly.

The critically important fact: liver transplant is the only proven cure for HPS — and HPS qualifies for MELD exception points, potentially accelerating your transplant timeline.

How it works — the gas exchange problem

In healthy lungs, blood passes through microscopic capillaries that are just wide enough for red blood cells to squeeze through single-file. This close contact between blood cells and the thin capillary walls allows efficient oxygen transfer — each red blood cell gets fully loaded with oxygen before leaving the lung.

In HPS, substances released by the diseased liver (including nitric oxide and other vasodilators) cause these pulmonary capillaries to dilate dramatically — sometimes to 5–10 times their normal diameter. When capillaries are this wide, blood rushes through too fast, and red blood cells in the center of the dilated vessel are too far from the capillary wall to pick up oxygen efficiently. Some blood passes through the lung without being oxygenated at all — a phenomenon called intrapulmonary shunting.

The oxygen that enters your blood in the normal capillaries isn't enough to compensate for the blood that bypasses gas exchange in the dilated ones. Your arterial oxygen drops. You feel breathless. And because gravity pulls more blood to the dilated vessels at the lung bases when you're upright, the oxygenation problem worsens when you stand — explaining the characteristic worsening of breathlessness in the upright position.

Symptoms

• Shortness of breath — progressive, initially with exertion, eventually at rest. The hallmark: breathlessness that's worse when standing or sitting upright and improves when lying flat (the opposite of what you'd expect with heart failure or hydrothorax).

• Platypnea-orthodeoxia — the specific HPS pattern: dyspnea (breathlessness) when upright that improves when lying down, with a measurable drop in oxygen saturation when moving from supine to upright position. If your SpO2 drops by 5% or more when you stand up from lying down — that's a clinical signal.

• Cyanosis — bluish discoloration of lips and fingertips from low oxygen.

• Spider angiomas — spider nevi may be more prevalent in HPS patients (the same vasodilatory process affecting skin vessels).

• Clubbing — widening and rounding of fingertips and nails, a sign of chronic low oxygen.

Diagnosis

HPS diagnosis requires three criteria simultaneously:

1. Liver disease — usually cirrhosis with portal hypertension, though HPS can occur with non-cirrhotic portal hypertension.

2. Arterial hypoxemia — PaO2 (partial pressure of oxygen in arterial blood) below 80 mmHg on room air, or an increased alveolar-arterial (A-a) gradient above 15 mmHg (above 20 mmHg in patients over 64).

3. Intrapulmonary vascular dilations (IPVDs) — demonstrated by contrast-enhanced echocardiography (the gold standard diagnostic test). Agitated saline ("bubble study") is injected intravenously. In normal lungs, the microbubbles are filtered by the tiny capillaries and never reach the left heart. In HPS, the dilated capillaries allow bubbles to pass through to the left heart — appearing on echo 3–6 heartbeats after injection (the delay distinguishes intrapulmonary shunting from intracardiac shunting, where bubbles appear within 1–2 beats).

Additional testing: arterial blood gas (ABG) in both supine and upright positions (to document orthodeoxia), pulse oximetry monitoring (SpO2 at rest and with exertion), pulmonary function tests (may be normal or show only reduced diffusion capacity), and CT angiography (in some cases, to visualize dilated pulmonary vessels).

Severity classification

Treatment

There is no effective medical therapy for HPS

No medication has been convincingly shown to reverse pulmonary vascular dilation in HPS. Trials of inhaled nitric oxide antagonists, garlic supplements, pentoxifylline, and other agents have been disappointing. Supplemental oxygen provides symptomatic relief but doesn't treat the underlying problem.

Liver transplant is the cure

Transplant resolves HPS in the majority of patients — the new liver normalizes the vasodilatory signals, and the pulmonary capillaries gradually return to normal caliber. Oxygenation improves over weeks to months after transplant, with most patients achieving normal or near-normal oxygen levels by 6–12 months.

MELD exception points: HPS with PaO2 ≤60 mmHg qualifies for standardized MELD exception points through the National Liver Review Board (NLRB). This is critically important because HPS patients often have low "lab MELD" scores (their liver synthetic function may be relatively preserved) — meaning they wouldn't get timely transplant offers based on their MELD alone. The exception points raise their effective MELD to reflect the mortality risk their lung disease adds. If you have HPS, ensure your transplant team has submitted for exception points.

However, very severe HPS (PaO2 <50 mmHg) carries higher post-transplant mortality — the severely dilated vessels may not fully reverse, and the perioperative period is high-risk. Transplant timing is critical: early enough that HPS hasn't progressed to very severe, but after adequate evaluation and preparation.

Living with HPS

• Supplemental oxygen — prescribed when SpO2 consistently drops below 88% (resting or with exertion). Portable oxygen concentrators allow mobility outside the home.

• Monitor your oxygen — a pulse oximeter at home is essential. Track SpO2 at rest, with exertion, and in both supine and upright positions. Report sustained drops below 88% to your medical team.

• Activity modification — adjust activity level to what your oxygenation allows. Walking with supplemental oxygen is better than not walking at all. Exercise as tolerated — deconditioning worsens the functional impact of low oxygen.

• Track everything — upload labs, log ABG results and oxygen requirements in the imaging tracker, and share with your transplant team. Worsening oxygenation over serial measurements supports MELD exception escalation.

• Avoid high altitude — reduced atmospheric oxygen at altitude worsens HPS symptoms. Air travel may require supplemental oxygen (arrange through the airline with medical documentation). If you live at high altitude, discuss relocation considerations with your transplant team.

Frequently asked questions

Is HPS the same as hepatic hydrothorax?

No — completely different problems. Hepatic hydrothorax is fluid compressing the lung (mechanical problem — treated with diuretics, thoracentesis, TIPS). HPS is abnormal blood vessel dilation in the lungs (gas exchange problem — treated only with transplant). Both cause shortness of breath in liver patients, but the mechanisms, diagnostics, and treatments are entirely different.

Will I need oxygen forever?

If you receive a liver transplant and HPS resolves — no. Oxygen requirements typically decrease over weeks to months post-transplant as the pulmonary vessels normalize. Most transplanted HPS patients are off supplemental oxygen within 6–12 months. Without transplant, oxygen requirements tend to gradually increase as HPS progresses.

Does HPS affect my transplant eligibility?

HPS is actually an indication FOR transplant — and qualifies for MELD exception points (when PaO2 ≤60 mmHg). It may accelerate your path to transplant. Very severe HPS (PaO2 <50 mmHg) carries higher surgical risk, which may affect the transplant team's timing decisions — ideally, transplant happens before HPS reaches this threshold.

Can HPS develop without cirrhosis?

Rarely — HPS has been reported in patients with non-cirrhotic portal hypertension (portal vein thrombosis, nodular regenerative hyperplasia) and even hepatitis without cirrhosis. The common factor is portal hypertension and/or hepatic dysfunction — not cirrhosis specifically. However, the vast majority of HPS cases occur in the setting of cirrhosis.

How is HPS different from portopulmonary hypertension?

Opposite vascular problems. HPS involves pulmonary blood vessel dilation (vessels too wide → poor gas exchange → low oxygen). Portopulmonary hypertension involves pulmonary blood vessel constriction (vessels too narrow → high pulmonary artery pressure → right heart strain). Both are liver-related lung complications, but they require different diagnostics (echocardiography and right heart catheterization for portopulmonary hypertension) and different management. Confusingly, both can coexist in the same patient.

When your liver makes your lungs stop working, transplant is the answer — and HPS qualifies for the exception points that get you there faster. Get tested. Get listed. Get breathing again.

→ Calculate Your MELD Score Free

→ Start Tracking Free

→ Log Your Results

Medical Disclaimer: This article is for informational and educational purposes only. HPS diagnosis and management require specialized pulmonary and hepatology expertise. If you experience worsening shortness of breath with liver disease, seek medical evaluation promptly. Visit livertracker.com/medical-disclaimer.